Location: Location not imported yet.
Title: Mpox in Central Africa: Complex epidemiology requires a constellation approachAuthor
HALBROOK, MEGAN - University Of California (UCLA) | |
MAKANGARA-CIGOLO, JEAN CLAUDE - Institute National Research Biomedical | |
MERRITT, SYDNEY - University Of California (UCLA) | |
HOFF, NICOLE - University Of California (UCLA) | |
LISENBORGHS, LAURENS - Institute Of Tropical Medicine | |
Hensley, Lisa | |
VERCAUTEREN, KOEN - Institute Of Tropical Medicine | |
MBALA-KINGEBENI, PLACIDE - Institute National Research Biomedical | |
RIMOIN, ANNE - University Of California (UCLA) | |
KINDRACHUK, JASON - University Of Manitoba |
Submitted to: npj Viruses
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 12/6/2024 Publication Date: N/A Citation: N/A Interpretive Summary: With the concurrent mpox outbreaks being reported in the Democratic Republic of the Congo (DRC) in 2024, and the evolving risk factors associated with both Clade 1a and 1b mpox, an effective and long lasting mpox response is of the utmost importance. This commentary discusses the systemic issues of mpox endemicity in the DRC and offers insight on control and mitigation efforts in this challenging global health context. Technical Abstract: With the concurrent mpox outbreaks being reported in the Democratic Republic of the Congo (DRC) in 2024, and the evolving risk factors associated with both Clade 1a and 1b mpox, an effective and long lasting mpox response is of the utmost importance. Current epidemiologic understandings of mpox in Central Africa have been confounded by underlying poor health and healthcare conditions. As mpox transmission dynamics continue to evolve public health response, particularly regarding vaccination, must take into account the social and economic context of the DRC. Investments in development, poverty relief, and infrastructure will be essential in curbing the spread of mpox in this region long term. |